News

The companies entered into an exclusive license in July 2014 to discover, develop and commercialize these products for the treatment of sepsis. Yabao Pharmaceutical R&D president Dr Peng

HepTcell is a peptide-based immunotherapeutic which includes the company’s proprietary Densigen technology. The product candidate includes nine long peptides covering conserved regions of core, polymerase and surface proteins

The initiation of this human trial follows strong pre-clinical results revealing that INO-5150 generated healthy CD8+ T cell responses in animal studies including non-human primates. The company noted

Narcan Nasal Spray has been granted Fast Track Designation by the FDA. Within 60 days of the submission date, the FDA will determine whether it will accept the

Fresenius Kabi Glucagon for Injection is indicated for use as a diagnostic aid during radiologic examinations and is available in 10-packs of 1mg vials. "Glucagon for Injection is

Unlike traditional insulin injections, Insulin PharmFilm, the proprietary nanoformulated transbuccal insulin film product delivers insulin through the use of a rapidly dissolving mucoadhesive film that is placed on

Invion and Hovione will collaborate to develop the proprietary novel technology — a dry powder formulation of the compound INV104 (zafirlukast) delivered by Hovione’s inhaler. Under the terms

Medytox, the Botulinum Toxin brand, occupies the highest market share in Korea, and is also the fourth company in the world successfully developed and produced Botulinum Toxin, leveraging

Upon closing of the transaction, which has been unanimously approved by the Boards of Directors of both the companies, Allergan will receive $33.75bn in cash and Teva shares